What we're reading, January 4, 2016: health insurers offering free doctor's visits for some plans; some consumers find paying the Affordable Care Act penalty cheaper than buying insurance; and clinicians and patients are increasingly worried about opioid dangers.
In more than a dozen markets across the countries, health insurers will be offering plans that include free doctor’s visits—no copays, coinsurance or expensive deductible. According to Kaiser Health News, the move is a response to reports that despite signing up for health coverage under the Affordable Care Act (ACA), many Americans have found high copays and deductibles make actually using their new health insurance too expensive.
Although 2016 is the year that penalties under the ACA’s individual mandate reach a tipping point so that purchasing health insurance is more affordable than paying the fine, this is not the case for all Americans. While the number of new enrollees is 29% higher than the same time last year, there are plenty of holdouts remaining, reported The New York Times. These individuals earn too much to qualify for federal subsidies and would prefer to hope they stay healthy throughout the year.
Clinicians and patients are increasingly concerned about the dangers of opioids. About two-thirds of health professionals believe patients are frequently taking more than prescribed and 69% said they are prescribing fewer opioids than in the past. In addition, almost half (46%) of patients agreed these drugs are being used in ways other than they had been prescribed, reported Medscape. However, only 23% of consumers report disposing of unused opioids, while 42% store these unused pills for future use, WebMD found.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen